Charles van Es - 08 Dec 2025 Form 4 Insider Report for Vita Coco Company, Inc. (COCO)

Role: Chief Sales Officer
Signature: By: Alison Klein, Attorney-in-Fact For: Charles Van Es
Issuer symbol: COCO
Transactions as of: 08 Dec 2025
Net transactions value: $0
Form type: 4
Filing time: 09 Dec 2025, 17:09:06 UTC
Previous filing: 01 Dec 2025
Next filing: 26 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
van Es Charles	Chief Sales Officer	111 5TH AVENUE, 2ND FLOOR, NEW YORK	By: Alison Klein, Attorney-in-Fact For: Charles Van Es	09 Dec 2025	0001886344

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	COCO	Common Stock	Gift	$0	-1,400	-1.8%	$0.000000	77,628	08 Dec 2025	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	COCO	Non-Qualified Stock Option (right to buy)						53,750	08 Dec 2025	Common Stock	53,750	$10.18	Direct	F2
holding	COCO	Non-Qualified Stock Option (right to buy)						27,300	08 Dec 2025	Common Stock	27,300	$10.18	Direct	F3
holding	COCO	Non-Qualified Stock Option (right to buy)						58,043	08 Dec 2025	Common Stock	58,043	$15.00	Direct	F4
holding	COCO	Non-Qualified Stock Option (right to buy)						42,980	08 Dec 2025	Common Stock	42,980	$15.36	Direct	F5
holding	COCO	Non-Qualified Stock Option (right to buy)						14,205	08 Dec 2025	Common Stock	14,205	$16.91	Direct	F6
holding	COCO	Non-Qualified Stock Option (right to buy)						8,746	08 Dec 2025	Common Stock	8,746	$26.18	Direct	F7
holding	COCO	Non-Qualified Stock Option (right to buy)						13,218	08 Dec 2025	Common Stock	13,218	$33.36	Direct	F8

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On December 8, 2025, the reporting person donated 1,400 shares of the Company's common stock to a donor-advised fund for charitable purposes.
F2	The stock option is fully vested and currently exercisable.
F3	The stock option is fully vested and currently exercisable.
F4	The stock option vests in four equal annual installments beginning on November 27, 2022.
F5	The stock option vests in three equal annual installments beginning on August 15, 2025.
F6	The stock option vests in four equal annual installments beginning on March 10, 2024.
F7	The stock option vests in four equal annual installments beginning on March 4, 2025.
F8	The Reporting Person was granted stock options that will vest in four annual equal installments on each anniversary of the grant date provided that the Reporting Person remains in continuous service on each vesting date.